Biller Scott 4
4 · AGIOS PHARMACEUTICALS INC · Filed Jun 13, 2019
Insider Transaction Report
Form 4
Biller Scott
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common stock
2019-06-11$2.34/sh+7,218$16,872→ 33,729 total - Exercise/Conversion
Stock option (right to buy)
2019-06-11−7,218→ 0 totalExercise: $2.34Exp: 2022-04-05→ Common stock (7,218 underlying)
Holdings
- 53,059(indirect: See footnote)
Common stock
Footnotes (2)
- [F1]Shares held by a trust, of which the reporting person is trustee and beneficiary.
- [F2]This option was granted on April 6, 2012 for the purchase of 63,636 shares of common stock. The option vests as to 25% of the shares upon the achievement of a performance milestone, as to an additional 50% upon the achievement of a second performance milestone, and as to the remaining 25% on the first anniversary of the first date that both performance milestones were achieved. The performance criteria for the first performance milestone were met on March 18, 2013. The performance criteria for the second performance milestone were met on April 4, 2014, resulting in the vesting of the option as to 31,818 shares, and the remaining 15,909 shares vested on April 4, 2015.